|
1
|
Heidemann LN, Hartwell D, Heidemann CH and
Jochumsen KM: The relation between endometriosis and ovarian cancer
- a review. Acta Obstet Gynecol Scand. 93:20–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petrillo M, Legge F, Ferrandina G,
Monterisi A, Pedone Anchora L and Scambia G: Fertility-sparing
surgery in ovarian cancer extended beyond the ovaries: A case
report and review of the literature. Gynecol Obstet Invest. 77:1–5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kobayashi O, Sugiyama Y, Cho H, Tsuburaya
A, Sairenji M, Motohashi H and Yoshikawa T: Clinical and
pathological study of gastric cancer with ovarian metastasis. Int J
Clin Oncol. 8:67–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raavé R, de Vries RB, Massuger LF, van
Kuppevelt TH and Daamen WF: Drug delivery systems for ovarian
cancer treatment: A systematic review and meta-analysis of animal
studies. PeerJ. 3:e14892015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gallardo-Rincón D, Espinosa-Romero R,
Muñoz WR, Mendoza-Martínez R, Villar-Álvarez SD, Oñate-Ocaña L,
Isla-Ortiz D, Márquez-Manríquez JP, Apodaca-Cruz Á and
Meneses-García A: Epidemiological overview, advances in diagnosis,
prevention, treatment and management of epithelial ovarian cancer
in Mexico. Salud Publica Mex. 58:302–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ganesan P, Kumar L, Hariprasad R, Gupta A,
Dawar R and Vijayaraghavan M: Improving care in ovarian cancer: The
role of a clinico-pathological meeting. Natl Med J India.
21:225–227. 2008.PubMed/NCBI
|
|
7
|
Jin F, Li HS, Zhao L, Wei YJ, Zhang H, Guo
YJ, Pang R, Jiang XB and Zhao HY: Expression of anti-apoptotic and
multi-drug resistance-associated protein genes in cancer stem cell
isolated from TJ905 glioblastoma multiforme cell line. Zhonghua Yi
Xue Za Zhi. 88:2312–2316. 2008.(In Chinese). PubMed/NCBI
|
|
8
|
Hamada S, Masamune A, Miura S, Satoh K and
Shimosegawa T: miR-365 induces gemcitabine resistance in pancreatic
cancer cells by targeting the adaptor protein SHC1 and
pro-apoptotic regulator BAX. Cell Signal. 26:179–185. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shiota M, Yokomizo A and Naito S:
Pro-survival and anti-apoptotic properties of androgen receptor
signaling by oxidative stress promote treatment resistance in
prostate cancer. Endocr Relat Cancer. 19:R243–R253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang TM, Barbone D, Fennell DA and
Broaddus VC: Bcl-2 family proteins contribute to apoptotic
resistance in lung cancer multicellular spheroids. Am J Respir Cell
Mol Biol. 41:14–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zaffaroni N, Pennati M, Colella G, Perego
P, Supino R, Gatti L, Pilotti S, Zunino F and Daidone MG:
Expression of the anti-apoptotic gene survivin correlates with
taxol resistance in human ovarian cancer. Cell Mol Life Sci.
59:1406–1412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing H, Weng D, Chen G, Tao W, Zhu T, Yang
X, Meng L, Wang S, Lu Y and Ma D: Activation of
fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by
regulating survivin protein expression in ovarian and breast cancer
cells. Cancer Lett. 261:108–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liguang Z, Peishu L, Hongluan M, Hong J,
Rong W, Wachtel MS and Frezza EE: Survivin expression in ovarian
cancer. Exp Oncol. 29:121–125. 2007.PubMed/NCBI
|
|
14
|
Cheng JC, Auersperg N and Leung PC:
TGF-beta induces serous borderline ovarian tumor cell invasion by
activating EMT but triggers apoptosis in low-grade serous ovarian
carcinoma cells. PLoS One. 7:e424362012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song J: EMT or apoptosis: A decision for
TGF-beta. Cell Res. 17:289–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gal A, Sjöblom T, Fedorova L, Imreh S,
Beug H and Moustakas A: Sustained TGF beta exposure suppresses Smad
and non-Smad signalling in mammary epithelial cells, leading to EMT
and inhibition of growth arrest and apoptosis. Oncogene.
27:1218–1230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chorna I, Bilyy R, Datsyuk L and Stoika R:
Comparative study of human breast carcinoma MCF-7 cells differing
in their resistance to doxorubicin: effect of ionizing radiation on
apoptosis and TGF-beta production. Exp Oncol. 26:111–117.
2004.PubMed/NCBI
|
|
18
|
Yao YH, Cui Y, Qiu XN, Zhang LZ, Zhang W,
Li H and Yu JM: Attenuated LKB1-SIK1 signaling promotes
epithelial-mesenchymal transition and radioresistance of non-small
cell lung cancer cells. Chin J Cancer. 35:502016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kruger W, Jung R, Kröger N, Gutensohn K,
Fiedler W, Neumaier M, Jänicke F, Wagener C and Zander AR:
Sensitivity of assays designed for the detection of disseminated
epithelial tumor cells is influenced by cell separation methods.
Clin Chem. 46:435–436. 2000.PubMed/NCBI
|
|
20
|
Zhang S, Balch C, Chan MW, Lai HC, Matei
D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and
characterization of ovarian cancer-initiating cells from primary
human tumors. Cancer Res. 68:4311–4320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scherer O, Maeß MB, Lindner S, Garscha U,
Weinigel C, Rummler S, Werz O and Lorkowski S: A procedure for
efficient non-viral siRNA transfection of primary human monocytes
using nucleofection. J Immunol Methods. 422:118–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Renshaw A and Elsheikh TM: A validation
study of the Focalpoint GS imaging system for gynecologic cytology
screening. Cancer Cytopathol. 121:737–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi M, Chiba A, Izawa H, Yanagida E,
Okamoto M, Shimodaira S, Yonemitsu Y, Shibamoto Y, Suzuki N and
Nagaya M: DC-vaccine study group at the Japan Society of Innovative
Cell Ther: The feasibility and clinical effects of dendritic
cell-based immunotherapy targeting synthesized peptides for
recurrent ovarian cancer. J Ovarian Res. 7:482014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ebell MH, Culp MB and Radke TJ: A
systematic review of symptoms for the diagnosis of ovarian cancer.
Am J Prev Med. 50:384–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barrett CL, DeBoever C, Jepsen K, Saenz
CC, Carson DA and Frazer KA: Systematic transcriptome analysis
reveals tumor-specific isoforms for ovarian cancer diagnosis and
therapy. Proc Natl Acad Sci USA. 112:pp. E3050–E3057. 2015;
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duda K, Cholewa H, Łabuzek K,
Boratyn-Nowicka A and Okopień B: Novel strategies of ovarian cancer
treatment. Pol Merkur Lekarski. 39:337–342. 2015.(In Polish).
PubMed/NCBI
|
|
28
|
Monteith GR: Prostate cancer cells alter
the nature of their calcium influx to promote growth and acquire
apoptotic resistance. Cancer Cell. 26:1–2. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moody SE, Schinzel AC, Singh S, Izzo F,
Strickland MR, Luo L, Thomas SR, Boehm JS, Kim SY, Wang ZC and Hahn
WC: PRKACA mediates resistance to HER2-targeted therapy in breast
cancer cells and restores anti-apoptotic signaling. Oncogene.
34:2061–2071. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Haslehurst AM, Koti M, Dharsee M, Nuin P,
Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, et al: EMT
transcription factors snail and slug directly contribute to
cisplatin resistance in ovarian cancer. BMC Cancer. 12:912012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thériault BL, Shepherd TG, Mujoomdar ML
and Nachtigal MW: BMP4 induces EMT and Rho GTPase activation in
human ovarian cancer cells. Carcinogenesis. 28:1153–1162. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takai M, Terai Y, Kawaguchi H, Ashihara K,
Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M,
et al: The EMT (epithelial-mesenchymal-transition)-related protein
expression indicates the metastatic status and prognosis in
patients with ovarian cancer. J Ovarian Res. 7:762014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lili LN, Matyunina LV, Walker LD, Wells
SL, Benigno BB and McDonald JF: Molecular profiling supports the
role of epithelial-to-mesenchymal transition (EMT) in ovarian
cancer metastasis. J Ovarian Res. 6:492013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ford CE, Jary E, Ma SS, Nixdorf S,
Heinzelmann-Schwarz VA and Ward RL: The Wnt gatekeeper SFRP4
modulates EMT, cell migration and downstream Wnt signalling in
serous ovarian cancer cells. PLoS One. 8:e543622013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang RY, Chung VY and Thiery JP:
Targeting pathways contributing to epithelial-mesenchymal
transition (EMT) in epithelial ovarian cancer. Curr Drug Targets.
13:1649–1653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mao Y, Xu J, Li Z, Zhang N, Yin H and Liu
Z: The role of nuclear β-catenin accumulation in the Twist2-induced
ovarian cancer EMT. PLoS One. 8:e782002013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y,
Xie Y, Sun X, Feng Y, Janzen V and Chen T: Transformation of
epithelial ovarian cancer stemlike cells into mesenchymal lineage
via EMT results in cellular heterogeneity and supports tumor
engraftment. Mol Med. 18:1197–1208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang J, Wang J, Fan L, Li X, Liu N, Luo W,
Wang J and Wang Y and Wang Y: cRGD inhibits vasculogenic mimicry
formation by down-regulating uPA expression and reducing EMT in
ovarian cancer. Oncotarget. 7:24050–24062. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cha Y, Kim DK, Hyun J, Kim SJ and Park KS:
TCEA3 binds to TGF-beta receptor I and induces Smad-independent,
JNK-dependent apoptosis in ovarian cancer cells. Cell Signal.
25:1245–1251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tanwar PS, Mohapatra G, Chiang S, Engler
DA, Zhang L, Kaneko-Tarui T, Ohguchi Y, Birrer MJ and Teixeira JM:
Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface
epithelium induces papillary serous ovarian cancer. Carcinogenesis.
35:546–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu T, Qin W, Hou L and Huang Y:
MicroRNA-17 promotes normal ovarian cancer cells to cancer stem
cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
Tumour Biol. 36:1881–1893. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen JL, Chen F, Zhang TT and Liu NF:
Suppression of SIK1 by miR-141 in human ovarian cancer cell lines
and tissues. Int J Mol Med. 37:1601–1610. 2016. View Article : Google Scholar : PubMed/NCBI
|
